Pharmaceuticals - Union Register


Register of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/05/298
Active ingredient: Mifepristone
Indication: Treatment of Cushing’s syndrome secondary to ectopic ACTH secretion
Sponsor: Laboratoire HRA Pharma
15 rue Béranger, 75003 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/08/2005 Orphan designation EMEA/OD/022/05 (2005)2945 of 27/07/2005
25/08/2005 Change of name and/or address of sponsor
28/11/2016 Removal of orphan designation from Community Register